Mirae Asset Global ETFs Holdings
DNA icon

Mirae Asset Global ETFs Holdings’s Ginkgo Bioworks DNA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
21,933
+2,282
+12% +$19.1K ﹤0.01% 2445
2026
Q1 		$120K Buy
19,651
+476
+2% +$3.96K ﹤0.01% 2592
2025
Q4 		$159K Buy
19,175
+1,113
+6% +$12K ﹤0.01% 2456
2025
Q3 		$263K Sell
18,062
-3,227
-15% -$38.6K ﹤0.01% 2181
2025
Q2 		$240K Buy
+21,289
New +$165K ﹤0.01% 2189

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DNA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Ginkgo Bioworks (DNA) stake by 12% in Q2 2026, buying an estimated $19.1K and bringing the position to 21,933 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #2445.

Mirae Asset Global ETFs Holdings first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $263K in Q3 2025. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 21,933 shares of Ginkgo Bioworks worth $217K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 2,282 Ginkgo Bioworks shares in Q2 2026, an estimated $19.1K.
  • Ginkgo Bioworks made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2445 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • Mirae Asset Global ETFs Holdings's Ginkgo Bioworks position peaked at $263K in Q3 2025.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.